Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Gastrointestinal Endoscopy|December 12, 2017
Computer-aided diagnosis for identifying and delineating early gastric cancers in magnifying narrow-band imagingTakashi Kanesaka, Tsung-Chun Lee, Noriya Uedo, et al.
Open Forum Infectious Diseases|August 21, 2020
Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in TaiwanTsung-Hua Yang, Yu-Jen Fang, Shih-Jer Hsu, et al.
Journal of Gastroenterology and Hepatology|July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virusYu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
International Journal of Colorectal Disease|October 19, 2011
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameterMing-Lun Han, Yi-Chia Lee, Chieh-Chang Chen, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2011
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trialJyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 8, 2019
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis CShih-Jer Hsu, Min-Chin Chiu, Yu-Jen Fang, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trialsMei-Jyh Chen, Ming-Shiang Wu, Chien-Chuan Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 14, 2020
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in TaiwanYu-Jen Fang, Mei-Jyh Chen, Chieh-Chang Chen, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2025
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus InfectionYu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, et al.
Journal of Medical Virology|May 15, 2024
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antiviralsChen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, et al.
Pageof 3